The International Hemoglobinopathy Research Network (<scp>INHERENT</scp>): An international initiative to study the role of genetic modifiers in hemoglobinopathies
Petros Kountouris(Cyprus Institute of Neurology and Genetics), Marina Kleanthous(Cyprus Institute of Neurology and Genetics), Obiageli Nnodu(University of Abuja), Ambroise Wonkam(University of Cape Town), Léon Tshilolo(National Institute of Biomedical Research), Fedele Bonifazi(Gianni Benzi Pharmacological Research Foundation), Aurelio Maggio(University of Palermo), Siana Nkya(Muhimbili University of Health and Allied Sciences), Sara Trompeter(NHS Blood and Transplant), Kyriaki Michailidou(University of Cambridge), Julie Makani(Muhimbili University of Health and Allied Sciences), Viviana Giannuzzi(Gianni Benzi Pharmacological Research Foundation), Kevin H.M. Kuo(Fudan University), Bin Alwi Zilfalil(Hospital Universiti Sains Malaysia), Natasha M. Archer(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Coralea Stephanou(Agruicultural Research Institute), María del Mar Mañú‐Pereira(Vall d'Hebron Institut de Recerca), Baba Inusa(St Thomas' Hospital)
Cited by 39
Related Papers
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
MicroRNA Related Polymorphisms and Breast Cancer Risk
|PLoS ONE|2014|638